Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C-Reference-Cited by-同舟云学术

Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C

Published:2021-06-08 Issue:8 Volume:28 Page:1177-1189
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Duffell Erika¹,Cortez‐Pinto Helena²,Simonova Marieta³,Dalgard Olav⁴,Dahl Elin Hoffmann⁵,de Martel Catherine⁶,Mozalevskis Antons⁷^ORCID,Buti Maria⁸,Pavlova Slava³,Hadzhilova Tnaiq³,Simões Carolina²,Katzarov Krum³,Mardh Otilia¹^ORCID

Affiliation:

1. European Centre for Disease Prevention and Control Stockholm Sweden

2. Laboratório de Nutrição Faculdade de Medicina Clínica Universitária de Gastrenterologia Universidade de Lisboa Lisboa Portugal

3. Department of Gastroenterology, HPB and Transplant Surgery Military Medical Academy Sofia Bulgaria

4. Department of Infectious Diseases Akershus University Hospital Lørenskog Norway

5. Department of Medicine Haukeland University Hospital Bergen Norway

6. Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer Lyon France

7. World Health Organization Regional Office for Europe Copenhagen Denmark

8. Liver Unit Hospital General Universitario Vall d'Hebron and CIBEREHD del Instituto Carlos III. Barcelona España

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13545

Reference24 articles.

1. EASL Recommendations on Treatment of Hepatitis C 2018

2. Towards the elimination and eradication of hepatitis B

3. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide

4. Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: A real-world retrospective study;Clinics and Research in Hepatology and Gastroenterology;2024-08

2. Hepatitis C Virus (HCV) and the Role of Phytochemicals in the Anti-Viral Effects of Different Medicinal Plants Against Infection;Reference Series in Phytochemistry;2023-11-01

3. Desmethoxycurcumin aids IFNα’s anti-HBV activity by antagonising CRYAB reduction and stabilising IFNAR1 protein;Journal of Drug Targeting;2023-10-21

4. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study;The Lancet Gastroenterology & Hepatology;2023-10

5. Mortality and morbidity related to hepatitis C virus infection in hospitalized adults—A propensity score matched analysis;Journal of Viral Hepatitis;2023-06-12